Abstract : Rupture of vulnerable plaques underlies most acute cardiovascular events. In article number1900005, Zheng Li and co‐workers develop a small‐molecule high‐affinity VEGFR‐PET radiopharmaceutical and validate it as a promising noninvasive in vivo imaging modality for timely discovery of vulnerable plaques in at‐risk patients.